Pinnacle Wealth Management Advisory Group’s Quest Diagnostics DGX Stock Holding History

Pinnacle Wealth Management Advisory Group’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$226K	Buy	+1,066	New	+$209K	0.01%	494

Other funds holding DGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Pinnacle Wealth Management Advisory Group's DGX Position: Q2 2026 in Review

Pinnacle Wealth Management Advisory Group opened a new position in Quest Diagnostics (DGX) in Q2 2026: 1,066 shares worth $226K. The stake represents 0.01% of the portfolio and ranks #494 among its holdings.

1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

Pinnacle Wealth Management Advisory Group held 1,066 shares of Quest Diagnostics worth $226K as of Q2 2026.
Quest Diagnostics was a new Pinnacle Wealth Management Advisory Group position in Q2 2026.
Quest Diagnostics made up 0.01% of Pinnacle Wealth Management Advisory Group's portfolio in Q2 2026, its #494 holding.
1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Pinnacle Wealth Management Advisory Group's 13F filing for Q2 2026, filed 5 Aug 2026.